High-dose cisplatin in advanced head and
✍
Arlene A. Forastiere; Bonnie J. Takasugi; Shan R. Baker; Gregory T. Wolf; Vickie
📂
Article
📅
1987
🏛
Springer
🌐
English
⚖ 452 KB
In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with